Clinical controversy and research progress of post-cholecystectomy syndrome

doi:10.16139/j.1007-9610.2025.03.14

Abstract

Abstract:

Post-cholecystectomy syndrome (PCS) encompasses persistent or new abdominal pain, bloating, and diarrhea following cholecystectomy. Our understanding of its etiology, diagnosis, and treatment has evolved significantly. This systematic review traced the conceptual progression of PCS and addressed clinical controversies, and reflections on diagnostic and therapeutic improvements. The definition of PCS has shifted from an anatomical focus (e.g., retained stones, biliary duct injury) to functional disorders (e.g., sphincter of Oddi dysfunction, abnormal bile acid metabolism, and psychosomatic factors). Current diagnosis strictly adheres to the Rome Ⅳ criteria, with an approximate prevalence of 10%. Historically broad diagnostic criteria explained the wide variability in reported incidence rates (5%-63%). Ambiguity persists regarding whether pre-existing symptoms persisting or evolving postoperatively should be attributed to PCS.Therapeutic approaches have transitioned from definitive surgical interventions for organic lesions to pharmacological management of functional dyspepsia. Given the inherent conceptual ambiguity in PCS, we proposed replacing PCS with post-cholecystectomy biliary dyspepsia (PCBD)—a term emphasizing its postoperative onset, functional dyspepsia characteristics, and exclusion of preoperative symptoms or non-biliary etiologies. The introduction of the concept of PCBD can help to unify diagnostic criteria, guide individualized treatment, and conduct in-depth research.

Key words: Laparoscopic cholecystectomy(LC), Post-cholecystectomy syndrome(PCS), Post-cholecystectomy biliary dyspepsia(PCBD)

CLC Number:

R657.4

WU Yuzhao, CAI Jie, CHEN Shenhao, CHEN Xi, ZHENG Yamin. Clinical controversy and research progress of post-cholecystectomy syndrome[J]. Journal of Surgery Concepts & Practice, 2025, 30(03): 268-271.

References 24

[1]	LUNEVICIUS R, NZENWA I C, MESRI M. A nationwide analysis of gallbladder surgery in England between 2000 and 2019[J]. Surgery, 2022, 171(2):276-284.
[2]	ZHOU P H, LIU F L, YAO L Q, et al. Endoscopic diagnosis and treatment of post-cholecystectomy syndrome[J]. Hepatobiliary Pancreat Dis Int, 2003, 2(1):117-120.
[3]	ARORA D, KAUSHIK R, KAUR R, et al. Post-cholecystectomy syndrome: a new look at an old problem[J]. J Minim Access Surg, 2018, 14(3):202-207. doi: 10.4103/jmas.JMAS_92_17 pmid: 29067945
[4]	ZACKRIA R, LOPEZ R A. Postcholecystectomy syndrome[M]. Treasure Island (FL): StatPearls Publishing, 2023.
[5]	COLP R. The postcholecystectomy syndrome and its treatment[J]. Bull N Y Acad Med, 1944, 20(4):203-219. pmid: 19312391
[6]	BERK J E. Postcholecystectomy syndrome: a critical evaluation[J]. Gastroenterology, 1958, 34(6):1060-1074. pmid: 13548339
[7]	TREIDER M, OHNESORGE S, BJØRNLAND K. Post-cholecystectomy syndrome in pediatric patients: occurrence and spectrum of symptoms[J]. J Pediatr Surg, 2023, 58(3):564-567.
[8]	TULASSAY Z, PAPP J. Endoscopy in the postcholecystectomy syndrome[J]. Lancet, 1980, 2(8198):800. pmid: 6107476
[9]	SCHOFER J M. Biliary causes of postcholecystectomy syndrome[J]. J Emerg Med, 2010, 39(4):406-410. doi: 10.1016/j.jemermed.2007.11.090 pmid: 18722735
[10]	KOCH M, CAPURSO G. Functional dyspepsia: how could a biliary dyspepsia sub-group be recognized? A methodological approach[J]. Ital J Gastroenterol, 1996, 28(5):261-268.
[11]	JAUNOO S S, MOHANDAS S, ALMOND L M. Postcholecystectomy syndrome (PCS)[J]. Int J Surg, 2010, 8(1):15-17. doi: 10.1016/j.ijsu.2009.10.008 pmid: 19857610
[12]	SALEEM S, WEISSMAN S, GONZALEZ H, et al. Post-cholecystectomy syndrome: a retrospective study analy-sing the associated demographics, aetiology, and healthcare utilization[J]. Transl Gastroenterol Hepatol, 2021,6:58.
[13]	中华医学会外科学分会胆道外科学组,中国医师协会外科医师分会胆道外科医师委员会. 胆囊良性疾病外科治疗的专家共识(2021版)[J]. 中华外科杂志, 2022, 60(1):4-9.
	Branch of Biliary Surgery, Chinese Society of Surgery, Chinese Medical Association; Chinese Medical Doctor Association in Chinese Committee of Biliary Surgeons. Consensus on the surgical management of benign gallbladder diseases(2021 edition)[J]. Chin J Surg, 2022, 60(1):4-9.
[14]	MAHFOUZ M E M, ALTOWAIRQI A D M, ALGHAMDI H Y, et al. Prevalence and factors associated with post-cholecystectomy syndrome in Saudi Arabia[J]. Cureus, 2022, 14(12):e32827.
[15]	ISHERWOOD J, OAKLAND K, KHANNA A. A syste-matic review of the aetiology and management of post cholecystectomy syndrome[J]. Surgeon, 2019, 17(1):33-42.
[16]	TARNASKY P R. Post-cholecystectomy syndrome and sphincter of Oddi dysfunction: past, present and future[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(12):1359-1372.
[17]	SANGIORGIO G, ZANGHÌ M, DIONIGI G, et al. Postcholecystectomy syndrome: biliary-related complications[J]. Minerva Surg, 2023, 78(6):684-691.
[18]	ALOTAIBI A M. Post-cholecystectomy syndrome: a cohort study from a single private tertiary center[J]. J Taibah Univ Med Sci, 2022, 18(2):383-389.
[19]	MERTENS M C, ROUKEMA J A, SCHOLTES V P, et al. Risk assessment in cholelithiasis: is cholecystectomy always to be preferred?[J]. J Gastrointest Surg, 2010, 14(8):1271-1279. doi: 10.1007/s11605-010-1219-6 pmid: 20502977
[20]	SHABANZADEH D M. The symptomatic outcomes of cholecystectomy for gallstones[J]. J Clin Med, 2023, 12(5):1897.
[21]	KINGSTON R D, WINDSOR C W. Flatulent dyspepsia in patients with gallstones undergoing cholecystectomy[J]. Br J Surg, 1975, 62(3):231-233.
[25]	WEINERT C R, ARNETT D, JACOBS D Jr, et al. Relationship between persistence of abdominal symptoms and successful outcome after cholecystectomy[J]. Arch Intern Med, 2000, 160(7):989-995. doi: 10.1001/archinte.160.7.989 pmid: 10761964
[26]	KIM H, HAN I W, HEO J S, et al. Postcholecystectomy syndrome: symptom clusters after laparoscopic cholecystectomy[J]. Ann Surg Treat Res, 2018, 95(3):135-140. doi: 10.4174/astr.2018.95.3.135 pmid: 30182019
[27]	POOLE D P, GODFREY C, CATTARUZZA F, et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system[J]. Neurogastroenterol Motil, 2010, 22(7):814-825,e227-228.
[28]	LI W T, LUO Q Q, WANG B, et al. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis[J]. FASEB J, 2019, 33(2):2435-2450.
[29]	SPILLER R. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment[J]. F1000Res, 2016,5:780.
[30]	DOLDI S B, MICHELETTO G, MONTORSI W. Le dispepsie gastrointestinali biliodipendenti [Bile-dependent gastrointestinal dyspepsia][J]. Minerva Med, 1984, 75(34):1911-1919. pmid: 6483249
[22]	RÄDECKE J, WANINGER J, SCHLOTTERBECK E, et al. Folgezustände nach cholezystektomie-eine prospektive studie [Sequelae of cholecystectomy-a prospective study][J]. Zentralbl Chir, 1993, 118(6):337-341.
[23]	PETERLI R, MERKI L, SCHUPPISSER J P, et al. Postcholecystektomiebeschwerden ein jahr nach laparoskopischer cholecystektomie. Ergebnisse einer prospektiven untersuchung von 253 patienten [Postcholecystectomy complaints one year after laparoscopic cholecystectomy. Results of a prospective study of 253 patients][J]. Chirurg, 1998, 69(1):55-60. doi: 10.1007/s001040050373 pmid: 9522070
[24]	中华医学会外科学分会胆道外科学组,中国医师协会外科医师分会胆道外科医师委员会. 胆囊切除术后常见并发症的诊断与治疗专家共识(2018版)[J]. 全科医学临床与教育, 2018, 16(3):244-246.
	Section of Biliary Surgery, Branch of Surgery, Chinese Medical Association; Chinese Committee of Biliary Surgeons. Expert consensus on diagnosis and treatment of common complications after cholecystectomy (2018 edition)[J]. Clin Edu Gen Pract, 2018, 16(3):244-246.